{{htmlmetatags> metatag-keywords=(Fragilité) metatag-og:title=(The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials. Nguyen TN, et al, J Am Geriatr Soc 2025.) metatag-description=(Traduction du résumé de l'article : The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials. Nguyen TN, et al, Journal of the American Geriatrics Society 2025.) metatag-og:type=article metatag-article:published_time=2025-12-25 metatag-article:modified_time=2025-12-25 }} {{page>:priv:keywords&nofooter&noeditbtn}} ~~NOTOC~~ {{pmid>addtt:40105285|The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials.}} {{pmid>addhash_fr:40105285|Fragilité}} ====== The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials. Nguyen TN, et al, J Am Geriatr Soc 2025. ====== {{tag>Fragilité }} {{tag>Proposé_Via_Bot_Sans_HashTag}} * **Proposé le :** 25/12/2025 04:07:11 * **Par :** [[:user:Bot]] * **Avec la version du site :** * **Revu par :** * //Mettre votre nom d'utilisateur// * //Mettre votre nom d'utilisateur// {{tag>Proposé_à_relecture 2025-12 Non_attribué Non_finalisé}} {{page>:veille:info:part_authors_instructions&noindent&nolink&nofooter&noeditbtn}} ===== Résumé et points clés ===== {{pmid>abstract_html:40105285}} ===== Références de l'article ===== {{pmid>listgroup:40105285}} ---- {{page>:veille:pm:discussion:40105285&nofooter&nolink&noindent}} [[:veille:pm:discussion:40105285?do=edit|Éditer la discussion]] ---- ===== Références ===== ~~REFNOTES~~ {{page>:start_news:start_newsletter&noident&nofooter&noeditbtn}}